| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.768 | 0.001 | 0.768 | Lanosterol 14 alpha demethylase inhibitor | 0.356 0.002 DBMET03500 | ||
| 0.485 | 0.004 | 0.522 | Cell wall synthesis inhibitor | 0.522 0.003 DBMET03500 | DBMET03500 | |
| 0.355 | 0.028 | 0.355 | Anticonvulsant | |||
| 0.317 | 0.005 | 0.317 | GABA receptor agonist | |||
| 0.287 | 0.005 | 0.287 | Aromatase inhibitor | |||
| 0.278 | 0.005 | 0.278 | GABA A receptor agonist | |||
| 0.242 | 0.007 | 0.242 | Hedgehog signaling inhibitor | |||
| 0.247 | 0.021 | 0.247 | M18 aspartyl aminopeptidase inhibitor | 0.099 0.094 DBMET03500 | ||
| 0.237 | 0.018 | 0.237 | DNA intercalator | 0.195 0.027 DBMET03500 | ||
| 0.216 | 0.055 | 0.216 | P-glycoprotein inhibitor | 0.156 0.108 DBMET03500 | ||
| 0.216 | 0.065 | 0.217 | Nitric-oxide synthase stimulant | 0.217 0.064 DBMET03500 | DBMET03500 | |
| 0.176 | 0.034 | 0.176 | Cholesterol synthesis inhibitor | 0.148 0.046 DBMET03500 | ||
| 0.167 | 0.037 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.158 | 0.032 | 0.158 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.176 | 0.065 | 0.176 | Heat shock protein 90 alpha antagonist | |||
| 0.111 | 0.005 | 0.111 | Exportin-1 inhibitor | |||
| 0.136 | 0.044 | 0.136 | Ferrochelatase inhibitor | |||
| 0.117 | 0.042 | 0.117 | Breast cancer-resistant protein inhibitor | |||
| 0.113 | 0.039 | 0.113 | Glutamate (mGluR7) agonist | |||
| 0.074 | 0.005 | 0.074 | Glutamate (mGluR3) antagonist | |||
| 0.087 | 0.033 | 0.087 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.06 | 0.006 | 0.06 | Heme oxygenase inhibitor | |||
| 0.106 | 0.053 | 0.106 | Creatine kinase inhibitor | |||
| 0.061 | 0.011 | 0.061 | Glutamate (mGluR group II) antagonist | |||
| 0.062 | 0.013 | 0.062 | Dopamine beta hydroxylase inhibitor | |||
| 0.043 | 0.01 | 0.043 | Glutamate (mGluR2) antagonist | |||
| 0.051 | 0.022 | 0.051 | Geranyltranstransferase inhibitor | |||
| 0.059 | 0.031 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.058 | 0.031 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.045 | 0.021 | 0.045 | Alpha 1d adrenoreceptor agonist | |||
| 0.078 | 0.055 | 0.078 | Glutamate receptor agonist | |||
| 0.052 | 0.032 | 0.052 | Alpha 1b adrenoreceptor agonist | |||
| 0.072 | 0.054 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.056 | 0.041 | 0.056 | Pregnane X receptor antagonist | |||
| 0.018 | 0.004 | 0.018 | Egl nine homolog 3 inhibitor | |||
| 0.065 | 0.056 | 0.065 | HIV-1 integrase inhibitor | |||
| 0.026 | 0.023 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.08 | 0.082 | 0.12 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.12 0.039 DBMET03500 | DBMET03500 | |
| 0.127 | 0.136 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET03500 | DBMET03500 | |
| 0.068 | 0.108 | 0.166 | NADH dehydrogenase inhibitor | 0.166 0.014 DBMET03500 | DBMET03500 | |
| 0.078 | 0.126 | 0.111 | Beta amyloid protein antagonist | 0.111 0.077 DBMET03500 | DBMET03500 | |
| 0.063 | 0.123 | 0.119 | Triose-phosphate isomerase inhibitor | 0.119 0.033 DBMET03500 | DBMET03500 | |
| 0.03 | 0.11 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.017 DBMET03500 | DBMET03500 | |
| 0.14 | 0.226 | 0.294 | DNA synthesis inhibitor | 0.294 0.046 DBMET03500 | DBMET03500 | |
| 0.175 | 0.262 | 0.537 | Antibacterial | 0.537 0.031 DBMET03500 | DBMET03500 | |
| 0.068 | 0.17 | 0.141 | Alpha-N-acetylglucosaminidase inhibitor | 0.141 0.061 DBMET03500 | DBMET03500 | |
| 0.026 | 0.138 | 0.09 | Phosphofructokinase-1 inhibitor | 0.09 0.036 DBMET03500 | DBMET03500 | |
| 0.018 | 0.132 | 0.058 | Mannosidase inhibitor | 0.058 0.018 DBMET03500 | DBMET03500 | |
| 0.1 | 0.215 | 0.322 | Interleukin agonist | 0.322 0.038 DBMET03500 | DBMET03500 | |
| 0.008 | 0.134 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET03500 | DBMET03500 | |
| 0.01 | 0.139 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET03500 | DBMET03500 | |
| 0.134 | 0.268 | 0.362 | Immunomodulator | 0.362 0.056 DBMET03500 | DBMET03500 | |
| 0.086 | 0.254 | 0.169 | Interferon gamma antagonist | 0.169 0.058 DBMET03500 | DBMET03500 | |
| 0.041 | 0.227 | 0.12 | UDP-glucose 4-epimerase inhibitor | 0.12 0.043 DBMET03500 | DBMET03500 | |
| 0.047 | 0.233 | 0.227 | Amylase inhibitor | 0.227 0.035 DBMET03500 | DBMET03500 | |
| 0.043 | 0.253 | 0.146 | Beta glucuronidase inhibitor | 0.146 0.027 DBMET03500 | DBMET03500 | |
| 0.037 | 0.283 | 0.193 | AMP-activated protein kinase stimulant | 0.193 0.012 DBMET03500 | DBMET03500 | |
| 0.063 | 0.325 | 0.238 | NOS3 expression enhancer | 0.238 0.029 DBMET03500 | DBMET03500 | |
| 0.092 | 0.358 | 0.263 | Cholesterol antagonist | 0.263 0.116 DBMET03500 | DBMET03500 | |
| 0.043 | 0.314 | 0.16 | Toll-Like receptor 4 antagonist | 0.16 0.016 DBMET03500 | DBMET03500 | |
| 0.013 | 0.334 | 0.089 | Monophenol monooxygenase inhibitor | 0.089 0.085 DBMET03500 | DBMET03500 | |
| 0.018 | 0.344 | 0.063 | Heparanase inhibitor | 0.063 0.019 DBMET03500 | DBMET03500 | |
| 0.013 | 0.361 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.042 DBMET03500 | DBMET03500 | |
| 0.053 | 0.423 | 0.126 | DNA repair enzyme inhibitor | 0.126 0.062 DBMET03500 | DBMET03500 | |
| 0.018 | 0.4 | 0.14 | Topoisomerase I inhibitor | 0.14 0.045 DBMET03500 | DBMET03500 | |
| 0.041 | 0.436 | 0.368 | Nitric oxide antagonist | 0.368 0.029 DBMET03500 | DBMET03500 | |
| 0.039 | 0.436 | 0.175 | Antiamyloidogenic | 0.175 0.119 DBMET03500 | DBMET03500 | |
| 0.036 | 0.442 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 DBMET03500 | DBMET03500 | |
| 0.023 | 0.456 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.023 DBMET03500 | DBMET03500 | |
| 0.038 | 0.471 | 0.188 | Hemostatic | 0.188 0.038 DBMET03500 | DBMET03500 | |
| 0.028 | 0.476 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 DBMET03500 | DBMET03500 | |
| 0.079 | 0.553 | 0.134 | CC chemokine 6 receptor antagonist | 0.134 0.057 DBMET03500 | DBMET03500 | |
| 0.016 | 0.524 | 0.054 | Factor IXa inhibitor | 0.054 0.032 DBMET03500 | DBMET03500 | |
| 0.052 | 0.572 | 0.208 | Vasodilator, coronary | 0.208 0.175 DBMET03500 | DBMET03500 | |
| 0.021 | 0.546 | 0.228 | Hypolipemic | 0.228 0.078 DBMET03500 | DBMET03500 | |
| 0.067 | 0.624 | 0.712 | Antiinflammatory | 0.712 0.029 DBMET03500 | DBMET03500 | |
| 0.034 | 0.601 | 0.347 | Antithrombotic | 0.347 0.066 DBMET03500 | DBMET03500 | |
| 0.011 | 0.591 | 0.058 | Antibiotic Aminoglycoside-like | 0.058 0.009 DBMET03500 | DBMET03500 | |
| 0.021 | 0.63 | 0.281 | Transcription factor NF kappa B inhibitor | 0.281 0.106 DBMET03500 | DBMET03500 | |
| 0.066 | 0.695 | 0.411 | Interleukin 2 agonist | 0.411 0.024 DBMET03500 | DBMET03500 | |
| 0.026 | 0.687 | 0.367 | Immunosuppressant | 0.367 0.078 DBMET03500 | DBMET03500 | |
| 0.011 | 0.694 | 0.21 | Immunostimulant | 0.21 0.114 DBMET03500 | DBMET03500 | |
| 0.01 | 0.701 | 0.051 | Glucose-6-phosphate translocase inhibitor | 0.051 0.036 DBMET03500 | DBMET03500 | |
| 0.029 | 0.722 | 0.5 | Hypoglycemic | 0.5 0.015 DBMET03500 | DBMET03500 | |
| 0.029 | 0.735 | 0.622 | Cyclophilin D inhibitor | 0.622 0.024 DBMET03500 | DBMET03500 | |
| 0.009 | 0.724 | 0.228 | Platelet antagonist | 0.228 0.083 DBMET03500 | DBMET03500 | |
| 0.004 | 0.733 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.016 DBMET03500 | DBMET03500 | |
| 0.007 | 0.753 | 0.075 | Protein 50S ribosomal subunit inhibitor | 0.075 0.022 DBMET03500 | DBMET03500 | |
| 0.003 | 0.755 | 0.08 | Antineoplastic antibiotic | 0.08 0.057 DBMET03500 | DBMET03500 | |
| 0.056 | 0.855 | 0.31 | Peptidyltransferase inhibitor | 0.31 0.021 DBMET03500 | DBMET03500 | |
| 0.009 | 0.827 | 0.639 | Angiogenesis stimulant | 0.639 0.005 DBMET03500 | DBMET03500 | |
| 0.009 | 0.845 | 0.117 | Insulin secretagoues | 0.117 0.116 DBMET03500 | DBMET03500 | |
| 0.007 | 0.85 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.021 DBMET03500 | DBMET03500 | |
| 0.007 | 0.855 | 0.194 | Tumour necrosis factor alpha release inhibitor | 0.194 0.115 DBMET03500 | DBMET03500 | |
| 0.004 | 0.872 | 0.262 | Selectin antagonist | 0.262 0.008 DBMET03500 | DBMET03500 | |
| 0.015 | 0.896 | 0.341 | Hepatoprotectant | 0.341 0.02 DBMET03500 | DBMET03500 | |
| 0.021 | 0.902 | 0.326 | Caspase 3 stimulant | 0.326 0.067 DBMET03500 | DBMET03500 | |
| 0.017 | 0.916 | 0.519 | Apoptosis antagonist | 0.519 0.018 DBMET03500 | DBMET03500 | |
| 0.005 | 0.92 | 0.143 | Thrombolytic | 0.143 0.087 DBMET03500 | DBMET03500 | |
| 0.005 | 0.921 | 0.455 | Antioxidant | 0.455 0.026 DBMET03500 | DBMET03500 | |
| 0.007 | 0.951 | 0.319 | Platelet adhesion inhibitor | 0.319 0.028 DBMET03500 | DBMET03500 | |
| 0.004 | 0.963 | 0.254 | Free radical scavenger | 0.254 0.067 DBMET03500 | DBMET03500 | |
| 0.005 | 0.989 | 0.369 | Apoptosis agonist | 0.369 0.129 DBMET03500 | DBMET03500 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |